Serum Institute chief picks up 20 percent stake in Wakau
Advertisement
New Delhi: Serum Institute of India (SII) Chief Adar Poonawaalla has picked up a 20 per cent stake in Wakau Interactive, a short-video sharing platform and a subsidiary of JetSynthesys, for an undisclosed amount.
Poonawalla joins superstar Amitabh Bachchan as Wakau's league of investors. Financial details of the transaction were not disclosed.
Wakau - a community-driven social media platform - offers a combination of mobile-first screen experience and short video content in entertainment and fashion domains with an associated video-commerce element. Launched by digital entertainment and technology company JetSynthesys, Wakau has over 4 lakh curated user-generated videos and a song library featuring more than 10,000 curated regional and main media songs for short videos. Wakau currently has more than 5 lakh daily user engagement events, a statement said.
New content formats like short entertainment and fashion videos are gaining wide scale popularity and Wakau, leveraging its advanced AI based tech stack has made it so easy, creative, fun and safe for consumers with its high levels of personalisation. I'd like to congratulate the team on the AI award and am delighted to join this juggernaut of possibilities with Wakau as it sets off on its next phase of growth, Poonawalla said.
Read also: SII, Novavax get WHO EUL for Covovax
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.